2026年繆希椿老師實驗室論文發表-免疫所博士班秦偉堯
Macrophage anti-bacterial activity is controlled by adenylate kinase 4-mediated mitochondrial DNA synthesis
Wei-Yao Chin1, Ching-Tung Wu1, Gunn-Guang Liou2, Si-Tse Jiang3, Yi-Sheng Cheng4 5 6, Jr-Shiuan Lin1, Betty A Wu-Hsieh1, Shi-Chuen Miaw1
- Graduate Institute of Immunology, National Taiwan University College of Medicine , Taipei, Taiwan.
- Cryo-EM Core Facility of the First Core Laboratory, National Taiwan University College of Medicine , Taipei, Taiwan.
- National Laboratory Animal Center, National Applied Research Laboratories , Taipei, Taiwan.
- Genome and Systems Biology Degree Program, College of Life Science, National Taiwan University , Taipei, Taiwan.
- Department of Life Science, College of Life Science, National Taiwan University, Taipei, Taiwan.
- Institute of Plant Biology, College of Life Science, National Taiwan University , Taipei, Taiwan.
Abstract
Macrophage antibacterial activity requires mtROS production. The specific gene(s) that participates in the mtROS-mediated antibacterial process remains unclear. We showed that Listeria and Salmonella infections in human and mouse macrophages increased mtDNA copy number with which dictates antibacterial activity. Interestingly, adenylate kinase 4 (Ak4) expression was upregulated in macrophages after infection. Ak4 KO mice as well as macrophage-specific Ak4 KO mice became highly susceptible to bacterial infections. Ak4 is critical for the increase of mtDNA synthesis and mitochondrial mass in macrophages after bacterial infection. Biochemically, Ak4 transfers a phosphate group from ATP/GTP to (d)AMP for (d)ADP formation, and the K18A and G89S/A166D mutations abolished this function. Our results suggest that induction of Ak4 after infection produces more dADP, whose conversion to dATP in mitochondria supports mtDNA synthesis and the subsequent increase of mtROS production. Loss of this metabolic coupling in Ak4 KO macrophages diminishes antibacterial activity. Our findings highlight the vital role of Ak4 in macrophage defense against pathogenic bacteria.
Subjects: Infectious disease and host defense, Innate immunity and inflammation
J Exp Med. 2026 Apr 6;223(4):e20250978.